| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Revenues | 59,381 | 54,310 | ||
| Cost of revenue, excluding depreciation and amortization | 34,741 | 30,917 | ||
| Research and development | 1,784 | 2,563 | ||
| Clinical operations, net | 1,638 | 1,921 | ||
| Sales and marketing | 13,245 | 14,253 | ||
| General and administrative | 5,089 | 5,728 | ||
| Depreciation and amortization | 686 | 718 | ||
| Total costs and operating expenses | 57,183 | 56,100 | ||
| Income (loss) from operations | 2,198 | -1,790 | ||
| Financial income, net | -1,078 | -1,325 | ||
| Loss before taxes on income | 3,276 | -465 | ||
| Income tax expense (benefit) | 25 | 76 | ||
| Net income (loss) | 3,251 | -541 | ||
| Earnings per share - basic | 0.02 | - | ||
| Earnings per share - diluted | 0.02 | - | ||
| Weighted average number of shares outstanding, basic | 166,190,495 | 167,532,721 | ||
| Weighted average number of shares outstanding, diluted | 171,462,202 | 167,532,721 | ||
Talkspace, Inc. (TALKW)
Talkspace, Inc. (TALKW)